Discover

INKT
MiNK Therapeutics, Inc.
11.11
2 x 11.01
1 x 11.21
bid
ask
+
0.16
1.48%
12:36 PM
timesize
Ytd-0.34%
1y-9.06%
11.01
day range
11.56
8.48
52 week range
18.17
Open11.56Prev Close10.95Low11.01High11.56Mkt Cap55.20M
Vol1.51KAvg Vol26.29KEPS-2.80P/E-3.96Forward P/E-1.17
Beta0.48Short Ratio1.10Inst. Own2.25%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1350-d Avg11.43200-d Avg11.571yr Est6.50
Income Statement
Operating Expenses2.88M
Research and Development Expense1.20M
Selling, General and Administrative Expense1.68M
Operating Income-2.88M
Net Income-2.74M
Net Income Common Stock-2.74M
Net Income Common Stock (USD)-2.74M
Consolidated Income-2.74M
Earnings per Basic Share-0.57
Earnings per Basic Share (USD)-0.57
Earnings per Diluted Share-0.57
Earning Before Interest & Taxes (EBIT)-2.74M
Earning Before Interest & Taxes (USD)-2.74M
Weighted Average Shares4.80M
Weighted Average Shares Diluted4.80M
Balance Sheet
Cash and Equivalents9.53M
Cash and Equivalents (USD)9.53M
Current Assets10.02M
Property, Plant & Equipment Net354.52K
Total Assets10.38M
Current Liabilities7.29M
Total Liabilities23.06M
Accumulated Retained Earnings (Deficit)-159.42M
Accumulated Other Comprehensive Income-697.43K
Shareholders Equity-12.69M
Shareholders Equity (USD)-12.69M
Assets Non-Current354.52K
Liabilities Non-Current15.78M
Trade and Non-Trade Payables19.17M
Cash Flow
Depreciation, Amortization & Accretion36.07K
Net Cash Flow from Financing-2.10M
Net Cash Flow / Change in Cash & Cash Equivalents-3.83M
Issuance (Purchase) of Equity Shares3.15M
Issuance (Repayment) of Debt Securities -5.00M
Net Cash Flow from Operations-1.73M
Effect of Exchange Rate Changes on Cash -1.24K
Share Based Compensation630.39K